Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/9862
Title: | Low-level vancomycin resistance in Staphylococcus aureus--an Australian perspective. | Austin Authors: | Howden, Benjamin P ;Ward, P B;Johnson, Paul D R ;Charles, Patrick G P ;Grayson, M Lindsay | Affiliation: | Infectious Diseases | Issue Date: | 1-Feb-2005 | Publication information: | European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology; 24(2): 100-8 | Abstract: | Low-level vancomycin resistance in Staphylococcus aureus has emerged as a clinical problem over the past 8 years. The clinical relevance of this resistance has been questioned, and laboratory detection remains difficult and time consuming. There is, however, increasing evidence linking low-level vancomycin resistance with glycopeptide treatment failure in serious Staphylococcus aureus infections. Diagnostic laboratories and clinicians need to be aware of this resistance phenotype, to have procedures in place to detect the resistance, and to have strategies for managing patients with infections caused by resistant strains. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/9862 | DOI: | 10.1007/s10096-004-1261-y | ORCID: | Journal: | European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology | URL: | https://pubmed.ncbi.nlm.nih.gov/15682283 | Type: | Journal Article | Subjects: | Aged Aged, 80 and over Anti-Bacterial Agents.pharmacology Australia Humans Male Methicillin Resistance Microbial Sensitivity Tests Staphylococcal Infections.drug therapy.microbiology Staphylococcus aureus.drug effects Vancomycin Resistance |
Appears in Collections: | Journal articles |
Files in This Item:
File | Size | Format | |
---|---|---|---|
15682283.pdf | 56.6 kB | Adobe PDF | View/Open |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.